|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01952 EVEREST MED
Nominal 
48.980 +0.520 (+1.073%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 706,678 | 461.158% | 125,932 | 12,792 | 54 | 0 |
| Cost of Sales | (179,794) | 422.444% | (34,414) | (4,645) | (23) | -- |
| Gross Profit | 526,884 | 475.716% | 91,518 | 8,147 | 31 | -- |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 2,645 | -27.870% | 3,667 | (23,362) | (6,452) | (4,937,983) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (1,041,375) | 23.318% | (844,463) | (247,275) | (1,008,719) | (5,658,165) | |
| Taxation | 0 | -- | 0 | (8) | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (1,041,375) | 23.318% | (844,463) | (247,283) | (1,008,719) | (5,658,165) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (73,024) | -13.691% | (84,608) | (32,887) | (24,065) | 31,725 |
| Depreciation & Amortisation | 133,618 | 73.607% | 76,966 | 42,772 | 31,124 | 20,395 |
| Directors' Emoluments | 72,534 | 71.079% | 42,398 | 68,728 | 106,387 | 85,547 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -324.000 | 20.000% | -270.000 | -83.000 | -344.000 | -6,629.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (2.117) | -- | (2.457) | (3.883) | (2.489) | (5.529) |
| NBV per share ($) | 12.474 | -- | 15.349 | 18.118 | 19.737 | 23.331 |
| Remarks: | Real time quote last updated: 31/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -249,790 |
| %Change | -60.502% |
| EPS / (LPS) | RMB -0.770 |
| NBV Per Share (¥) | RMB 11.981 |